Articles related to ANTI-PSYCHOTICS

Neuroleptic malignant syndrome can mimic various disorders, including malignant hyperthermia, heat stroke, and serotonin syndrome, making accurate diagnosis crucial for appropriate management.

Expert psychiatric nurse practitioners stress the importance of familiarity with product inserts for each long-acting injectable antipsychotic to effectively manage missed doses in schizophrenia treatment.

Erzofri offers a new once-monthly injectable option for treating schizophrenia and schizoaffective disorder, potentially improving medication adherence for some patients.

Schizophrenia is a chronic brain disorder characterized by hallucinations, delusions, and cognitive impairments, affecting up to 1 percent of the global population. Understanding its symptoms, causes, and treatment options is crucial for effective patient care.

Effective management of tardive dyskinesia requires early prevention with second-generation antipsychotics and the use of VMAT2 inhibitors like deutetrabenazine and valbenazine, which offer the highest quality evidence for reducing symptoms.

Research presented at the APA 2024 Annual Meeting sheds light on innovative treatments and the multifaceted burden of anxiety disorders, highlighting significant advances in managing GAD and related comorbidities.